{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2\u2032-deoxy carbocyclic nucleoside", "Mitsunobu reaction", "antiviral activity", "hepatitis B virus"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34878718", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "05", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.1111/cbdd.13998"], "Journal": {"ISSN": "1747-0285", "JournalIssue": {"Volume": "99", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Apr"}}, "Title": "Chemical biology & drug design", "ISOAbbreviation": "Chem Biol Drug Des"}, "ArticleTitle": "Synthesis and antiviral activity of 2'-deoxy-6'-substituted carbocyclic nucleosides.", "Pagination": {"StartPage": "561", "EndPage": "572", "MedlinePgn": "561-572"}, "Abstract": {"AbstractText": ["A series of 2'-deoxy carbocyclic nucleosides characterized by various 6'-substitutions were synthesized and evaluated for their antiviral activities against three viruses, including hepatitis B virus (HBV), hepatitis C virus, and influenza virus. The in vitro antiviral assays indicated that these nucleosides only showed inhibitory activities against HBV, and the substituted groups at the 6' position significantly affected the activity. Among them, the guanosine analog 2b bearing a 6'-\u03b1-hydroxyl methyl group was the most potent compound with an EC<sub>50</sub> value of 80\u00a0nM. The present study provided useful information for the discovery of antiviral carbocyclic nucleosides."], "CopyrightInformation": "\u00a9 2021 John Wiley & Sons A/S."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Xue", "ForeName": "Haitao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Guo", "ForeName": "Shuang", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China."}], "LastName": "Hu", "ForeName": "Tianwen", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China."}], "LastName": "Wei", "ForeName": "Daibao", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}], "LastName": "Xie", "ForeName": "Yuanchao", "Initials": "Y"}, {"Identifier": ["0000-0001-9679-9934"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Shen", "ForeName": "Jingshan", "Initials": "J"}], "GrantList": [{"GrantID": "21S11903100", "Agency": "Shanghai Science and Technology Committee in China", "Country": ""}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chem Biol Drug Des", "NlmUniqueID": "101262549", "ISSNLinking": "1747-0277"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Nucleosides"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Hepacivirus"}, {"QualifierName": [], "DescriptorName": "Hepatitis B virus"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Nucleosides"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bessieres, M., Chevrier, F., Roy, V., & Agrofoglio, L. A. (2015). Recent progress for the synthesis of selected carbocyclic nucleosides. Future Medicinal Chemistry, 7(13), 1809-1828. https://doi.org/10.4155/fmc.15.105"}, {"Citation": "Bisacchi, G. S., Chao, S. T., Bachard, C., Daris, J. P., Innaimo, S., Jacobs, G. A., Kocy, O., Lapointe, P., Martel, A., Merchant, Z., Slusarchyk, W. A., Sundeen, J. E., Young, M. G., Colonno, R., & Zahler, R. (1997). BMS-200475, a novel carbocyclic 2\u2032-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro. Bioorganic & Medicinal Chemistry Letters, 7, 127-132. https://doi.org/10.1016/S0960-894X(96)00594-X"}, {"Citation": "Choi, W. J., Chung, H.-J., Chandra, G., Alexander, V., Zhao, L. X., Lee, H. W., Nayak, A., Majik, M. S., Kim, H. O., Kim, J.-H., Lee, Y. B., Ahn, C. H., Lee, S. K., & Jeong, L. S. (2012). Fluorocyclopentenyl-cytosine with broad spectrum and potent antitumor activity. Journal of Medicinal Chemistry, 55(9), 4521-4525. https://doi.org/10.1021/jm3004009"}, {"Citation": "Cihlar, T., & Ray, A. S. (2010). Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Research, 85(1), 39-58. https://doi.org/10.1016/j.antiviral.2009.09.014"}, {"Citation": "De Clercq, E. (2004). Antiviral drugs in current clinical use. Journal of Clinical Virology, 30(2), 115-133. https://doi.org/10.1016/j.jcv.2004.02.009"}, {"Citation": "Field, A. K., Tuomari, A. V., McGeever-Rubin, B., Terry, B. J., Mazina, K. E., Haffey, M. L., Hagen, M. E., Clark, J. M., Braitman, A., Slusarchyk, W. A., Young, M. G., & Zahler, R. (1990). (\u00b1)-(1\u03b1,2\u03b2,3\u03b1)-9-[2,3-bis(hydroxymethyl)-cyclobutyl]guanine [(\u00b1)-BHCG or SQ 33 054]: A potent and selective inhibitor of herpesviruses. Antiviral Research, 13(1), 41-52. https://doi.org/10.1016/0166-3542(90)90043-7"}, {"Citation": "Guo, S., Xu, M., Guo, Q. I., Zhu, F., Jiang, X., Xie, Y., & Shen, J. (2019). Discovery of pyrimidine nucleoside dual prodrugs and pyrazine nucleosides as novel anti-hcv agents. Bioorganic & Medicinal Chemistry, 27, 748-759. https://doi.org/10.1016/j.bmc.2019.01.007"}, {"Citation": "Hervey, P. S., & Perry, C. M. (2000). Abacavir: A review of its clinical potential in patients with HIV infection. Drugs, 60(2), 447-479. https://doi.org/10.2165/00003495-200060020-00015"}, {"Citation": "Kumamoto, H., Fukano, M., Imoto, S., Kohgo, S., Odanaka, Y., Amano, M., Kuwata-Higashi, N., Mitsuya, H., Haraguchi, K., & Fukuhara, K. (2017). A novel entecavir analogue constructing with a spiro[2.4]heptane core structure in the aglycon moiety: Its synthesis and evaluation for anti-hepatitis B virus activity. Nucleosides, Nucleotides & Nucleic Acids, 36(7), 463-473. https://doi.org/10.1080/15257770.2017.1322209"}, {"Citation": "Langley, D. R., Walsh, A. W., Baldick, C. J., Eggers, B. J., Rose, R. E., Levine, S. M., Kapur, A. J., Colonno, R. J., & Tenney, D. J. (2007). Inhibition of hepatitis B virus polymerase by entecavir. Journal of Virology, 81(8), 3992-4001. https://doi.org/10.1128/JVI.02395-06"}, {"Citation": "Leclerc, E. (2013). Chemical synthesis of nucleoside analogues (1st ed., pp. 535-604). Pedro Merino. https://onlinelibrary.wiley.com/doi/pdf/ https://doi.org/10.1002/9781118498088.ch12"}, {"Citation": "Liaw, Y. F., & Chu, C. M. (2009). Hepatitis B virus infection. The lancet, 373(9663), 582-592. https://doi.org/10.1016/S0140-6736(09)60207-5"}, {"Citation": "Marquez, V. E., Hughes, S. H., Sei, S., & Agbaria, R. (2006). The history of N-methanocarbathymidine: The investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. Antiviral Research, 71(2-3), 268-275. https://doi.org/10.1016/j.antiviral.2006.04.012"}, {"Citation": "Marquez, V. E., Lim, M. I., Treanor, S. P., Plowman, J., Priest, M. A., Markovac, A., Khan, M. S., Kaskar, B., & Driscoll, J. S. (1988). Cyclopentenylcytosine-A carbocyclic nucleoside with antitumor and antiviral properties. Journal of Medicinal Chemistry, 31(9), 1687-1694. https://doi.org/10.1021/jm00117a004"}, {"Citation": "Ono, N., Iwayama, S., Suzuki, K., Sekiyama, T., Nakazawa, H., Tsuji, T., & Nishiyama, Y. (1998). Mode of action of (1\u2032S,2\u2032R)-9-[[1\u2032,2\u2032-bis(hydroxymethyl) cycloprop-1\u2032-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus. Antimicrobial Agents & Chemotherapy, 42(8), 2095. https://doi.org/10.1128/AAC.42.8.2095"}, {"Citation": "Rawal, R. K., Bariwal, J., & Singh, V. (2016). Chemistry and bioactivities of aristeromycins: An overview. Current Topics in Medicinal Chemistry, 16(28), 3258-3273. https://doi.org/10.2174/1568026616666160506145300"}, {"Citation": "Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W. U., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-ncov) in vitro. Cell Research, 30(3), 1-3. https://doi.org/10.1038/s41422-020-0282-0"}, {"Citation": "Xu, H., Wang, F., Xue, W., Zheng, Y., Wang, Q. I., Qiu, F. G., & Jin, Y. (2018). Total synthesis of entecavir: A robust route for pilot production. Organic Process Research & Development, 22(3), 377-384. https://doi.org/10.1021/acs.oprd.8b00007"}, {"Citation": "Yoon, J.-S., Kim, G., Jarhad, D. B., Kim, H.-R., Shin, Y.-S., Qu, S., Sahu, P. K., Kim, H. O., Lee, H. W., Wang, S. B., Kong, Y. J., Chang, T.-S., Ogando, N. S., Kovacikova, K., Snijder, E. J., Posthuma, C. C., van Hemert, M. J., & Jeong, L. S. (2019). Design, synthesis, and anti-RNA virus activity of 6\u2032-fluorinated-aristeromycin analogues. Journal of Medicinal Chemistry, 62(13), 6346-6362. https://doi.org/10.1021/acs.jmedchem.9b00781"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "10", "Day": "6"}, {"Year": "2021", "Month": "6", "Day": "23"}, {"Year": "2021", "Month": "10", "Day": "23"}, {"Year": "2021", "Month": "12", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "8", "Hour": "12", "Minute": "32"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34878718", "10.1111/cbdd.13998"]}}], "PubmedBookArticle": []}